About Clontech
Clontech is a Healthcare company based in Palo Alto (United States) founded in 1984, and was acquired by Takara Bio in July 2005. Reagents, instruments, and services for life science industries are provided. Clontech offers products and services including Kits, Reagents, and Instruments. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is Takara Bio USA, Inc. Its competitors include Quanterix, Biocare Medical and Neogen; 3 of its 3 listed competitors have raised funding.
Company details
Clontech was founded in 1984 in Palo Alto, United States, within the life science sector. Reagents, instruments, and services are supplied for research applications. Products encompass PCR reagents, RT enzymes, library construction kits, cloning kits, and nucleic acidprotein purification tools. Services include gene discovery, protein analysis, plant and food research, and RNAi studies. Acquisition by Takara Bio was completed on July 1, 2005.
- Headquarters Palo Alto, United States
- Stage Acquired
- SectorsHealthcare
- Website clontech.com
- Social LinkedIn
- Acquired by Takara Bio (Jul 2005)
- Legal Name Takara Bio Usa, Inc.
- InvestorsTakara Bio
& 1 more
- Acquired byTakara Bio
(Jul 2005)
Products & Services of Clontech
Clontech offers a comprehensive portfolio of products and services, including Kits, Reagents, and Instruments.
Tools for gene discovery and nucleic acid purification
Substances for PCR and CRISPR applications
Devices for single-cell sequencing and analysis
Funding Insights of Clontech
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Clontech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 1999 | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Clontech
Clontech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Takara Bio and Summit Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Summit Partners is recognized as a growth equity investment firm. | summitpartners.com | Boston, United States | ||
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector | 1925 | takara-bio.com | Frankfurt, Germany |
Investor details for Clontech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Clontech
3 dated milestones of Clontech across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Clontech is founded.
- Funding First funding round.
- Exit Acquired by Takara Bio.
Competitors of Clontech
Clontech has 3 listed competitors in our database, 3 of them funded. They include Quanterix, Biocare Medical and Neogen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing |
Detailed competitors of Clontech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Clontech
Websites that share an audience with Clontech (clontech.com).
Websites whose visitors overlap most with Clontech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
evrogen.com | evrogen.com | 100% | #3,545,401 | – | |
promega.com | promega.com | 100% | #192,389 | – | |
| stratagene.com | 100% | View details | |||
| invitrogen.com | 100% | 5.2K | #3,688,642 | View details | |
| epibio.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 33 similar websites and full traffic analytics for Clontech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 33 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Clontech (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Clontech
Clontech was founded in 1984 and raised its 1st funding round 15 years after it was founded.
Clontech is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Clontech was founded in 1984 in Palo Alto, United States, within the life science sector. Reagents, instruments, and services are supplied for research applications. Products encompass PCR reagents, RT enzymes, library construction kits, cloning kits, and nucleic acidprotein purification tools. Services include gene discovery, protein analysis, plant and food research, and RNAi studies. Acquisition by Takara Bio was completed on July 1, 2005.
Clontech's top competitors include Neogen, Biocare Medical and Quanterix.
Clontech offers Kits, Reagents, and Instruments.
Clontech has 2 investors. Key investors include Takara Bio, and Summit Partners.
Clontech operates through Takara Bio Usa, Inc..
Yes. Clontech was acquired by Takara Bio in July 2005.